Cancer drug prices cut sharply; experts say pricing still too high
The drug price regulator NPPA has released new maximum prices for 543 anti-cancer medicine brands, and the cuts take effect from November 9. A health group says controlling trade margins alone is not enough. It argues that life-saving cancer treatment should be affordable based on medical need.
पार्श्वभूमीContext: NPPA is India's National Pharmaceutical Pricing Authority, which sets price limits for medicines. Cancer treatment is expensive for many families, so drug pricing is a recurring debate in Indian healthcare.
The Hindu: Sci-Tech वर वाचा (इंग्रजी)
बर्निंग पोटॅटो स्कोअर: 64%